Targeting low-risk triple-negative breast cancer: a review on de-escalation strategies for a new era
{{output}}
Triple-negative breast cancer (TNBC) is a subtype of breast cancer lacking estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression. Comprising 15-20% of breast cancers, TNBC is typically high-grade, af... ...
